title: A review of pathological diagnoses made from 87 canine splenic biopsies.
abstract: The pathological findings in 87 cases of canine splenic abnormality recognised clinically by abdominal palpation or radiography, or at exploratory laparotomy, are presented. The most common diagnosis was of splenic neoplasia (n = 38) and the most frequently recognised canine splenic neoplasm was haemangiosarcoma (17 of 38 cases). Benign splenic enlargement secondary to nodular hyperplasia (n = 6), haematoma (n = 16) or non-specific changes including congestion, haemorrhage, extramedullary haemopoiesis and haemosiderin deposition (n = 14) was also recognised. A diagnosis of non-specific pathology was more frequently recorded when portions of spleen, as opposed to the entire organ, were submitted for assessment. Splenic infarction, with (n = 3) or without (n = 7) torsion, abscessation (n = 2) and focal mast cell proliferation (n = 1) accounted for the remainder of the cases. Clinical follow-up was available for 35 cases and revealed good long-term survival in cases of splenic haematoma or haemangioma, with relatively poor survival with a diagnosis of splenic haemangiosarcoma or anaplastic sarcoma. A range of splenic disorders was recognised in dogs of the labrador breed (16 of 87 cases) and three of 17 cases of haemangiosarcoma occurred in German shepherd dogs. The possible predisposition of dogs of these breeds to splenic disorders is discussed.
authors.affiliation: Department of Pathology and Microbiology, University of Bristol, Langford.
authors.forename: M J
authors.initials: MJ
authors.lastname: Day
authors.forename: V M
authors.initials: VM
authors.lastname: Lucke
authors.forename: H
authors.initials: H
authors.lastname: Pearson
mesh_terms: D000038:Abscess / Q000473:pathology / Q000662:veterinary; D000230:Adenocarcinoma / Q000473:pathology / Q000662:veterinary; D000818:Animals; D001706:Biopsy; D004283:Dog Diseases / Q000473:pathology*; D004285:Dogs; D005260:Female; D005354:Fibrosarcoma / Q000473:pathology / Q000662:veterinary; D006391:Hemangioma / Q000473:pathology / Q000662:veterinary; D006394:Hemangiosarcoma / Q000473:pathology / Q000662:veterinary*; D006406:Hematoma / Q000473:pathology / Q000662:veterinary; D006965:Hyperplasia / Q000473:pathology / Q000662:veterinary; D007890:Leiomyosarcoma / Q000473:pathology / Q000662:veterinary; D008067:Lipoma / Q000473:pathology / Q000662:veterinary; D008297:Male; D008407:Mast Cells / Q000473:pathology; D012189:Retrospective Studies; D012509:Sarcoma / Q000473:pathology / Q000662:veterinary; D013154:Spleen / Q000473:pathology*; D013158:Splenic Diseases / Q000473:pathology / Q000662:veterinary*; D013159:Splenic Infarction / Q000473:pathology / Q000662:veterinary; D013160:Splenic Neoplasms / Q000473:pathology / Q000662:veterinary*; D013927:Thrombosis / Q000473:pathology / Q000662:veterinary; D014102:Torsion Abnormality